ROS-Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment.
Yangtao XuXiaoqin HeJunjian DengLin XiongBiao ChenJiayu ChenXiaoyu ZhangWenliang ChenXin LiuXinyao HuJiayi LiShan JiangYang ShenXiming XuPublished in: Oxidative medicine and cellular longevity (2022)
Reactive oxygen species (ROS) plays an essential role in the development of cancer. Here, we chose ROS-related miRNAs for consensus clustering analysis and ROS score construction. We find that ROS is extremely associated with prognosis, tumor immune microenvironment (TIME), gene mutations, N6-methyladenosine (m6A) methylation, and chemotherapy sensitivity in hepatocellular carcinoma (HCC). Mechanistically, ROS may affect the prognosis of HCC patients in numerous ways. Moreover, miR-210-3p and miR-106a-5p significantly increased the ROS level and stagnated cell cycle at G2/M in HCC; the results were more obvious in cells after ionizing radiation (IR). Finally, the two miRNAs suppressed cell proliferation, migration, and invasion and promoted apoptosis in huh7 and smmc7721 cells. It indicated that ROS might affect the prognosis of HCC patients through immune response and increase the sensitivity of HCC patients to radiotherapy and chemotherapy.
Keyphrases
- reactive oxygen species
- cell death
- end stage renal disease
- dna damage
- immune response
- cell cycle
- cell proliferation
- cell cycle arrest
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- locally advanced
- stem cells
- squamous cell carcinoma
- oxidative stress
- early stage
- patient reported outcomes
- inflammatory response
- signaling pathway
- dna methylation
- genome wide
- patient reported
- lymph node metastasis